On Tuesday, Lilly(Eli) & Co (NYSE: LLY) was 4.33% up from the session before settling in for the closing price of $773.71. A 52-week range for LLY has been $677.09 – $972.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 15.08% over the past five years. When this article was written, the company’s average yearly earnings per share was at 67.82%. With a float of $849.67 million, this company’s outstanding shares have now reached $948.10 million.
Let’s look at the performance matrix of the company that is accounted for 47000 employees. In terms of profitability, gross margin is 81.7%, operating margin of 40.7%, and the pretax margin is 27.75%.
Lilly(Eli) & Co (LLY) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Lilly(Eli) & Co stocks. The insider ownership of Lilly(Eli) & Co is 10.35%, while institutional ownership is 78.93%. The most recent insider transaction that took place on May 27 ’25, was worth 716,410. In this transaction SVP, Finance, & CAO of this company sold 1,000 shares at a rate of $716.41, taking the stock ownership to the 4,840 shares. Before that another transaction happened on May 14 ’25, when Company’s EVP & President, LLY Int’l sold 1,250 for $749.24, making the entire transaction worth $936,550. This insider now owns 27,510 shares in total.
Lilly(Eli) & Co (LLY) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 67.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.42% during the next five years compared to 18.77% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
You can see what Lilly(Eli) & Co (LLY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.61. Likewise, its price to free cash flow for the trailing twelve months is 204.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 12.07, a number that is poised to hit 5.56 in the next quarter and is forecasted to reach 29.65 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Lilly(Eli) & Co (NYSE: LLY) saw its 5-day average volume 3.17 million, a negative change from its year-to-date volume of 3.97 million. As of the previous 9 days, the stock’s Stochastic %D was 95.03%. Additionally, its Average True Range was 22.90.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 50.32%, which indicates a significant decrease from 98.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.11% in the past 14 days, which was lower than the 45.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $774.53, while its 200-day Moving Average is $828.99.
